Does J1620 require prior authorization?

No, J1620 does not require prior authorization (high confidence). Covered without prior authorization.

`J1620`, Injection, gonadorelin hydrochloride, per 100 mcg

HCPCS/CPT

No Prior Auth Required

Covered without prior authorization (high confidence)

Review and document the member's benefit contract or Summary Plan Description (SPD) to confirm whether the specific GnRH indication is a covered benefit, including checking for exclusions and benefit limitations (dollar or duration caps).

Gonadotropin-releasing hormone (GnRH) agonists/antagonists are medically necessary for the specific indications listed in the policy’s table, including endometriosis, uterine fibroids, and central precocious puberty (CPP) among others, as detailed in the drug-specific indications table.
GnRH agonists and antagonists may be medically necessary for listed indications (endometriosis, CPP, fibroids, preoperative anemia management in fibroids) as documented in the policy table; use is limited to FDA-labeled indications or as specified in the table of indications.
GnRH agonists/antagonists are medically necessary for the listed indications (endometriosis, fibroids, CPP in children, and related pediatric uses) as described in the policy table; treatment must be within labeled indications and as summarized in the table of FDA-labeled uses.
Cetrotide (cetrorelix acetate): medically necessary for inhibition of premature luteinizing hormone (LH) surges in women undergoing controlled ovarian stimulation.
Ganirelix (ganirelix acetate): medically necessary for inhibition of premature luteinizing hormone (LH) surges in women undergoing controlled ovarian hyperstimulation.
Goserelin (Zoladex® 3.6 mg): medically necessary for management of endometriosis (pain relief and lesion reduction) in women ≥18 years for up to 6 months; for use as an endometrial-thinning agent prior to endometrial ablation for dysfunctional uterine bleeding; and for dysfunctional uterine bleeding.

BCBSIL-RX501.041, Gonadotropin-Releasing Hormone (GnRH) Agonists and Antagonists

BCBSMT-RX501.041, Gonadotropin-Releasing Hormone (GnRH) Agonists and Antagonists

BCBSNM-RX501.041, Gonadotropin-Releasing Hormone (GnRH) Agonists and Antagonists

BCBSOK-RX501.041, Gonadotropin-Releasing Hormone (GnRH) Agonists and Antagonists

Ask Backwork about documentation requirements, denial risks, or coverage in your state.